0,1
"7.6.3	
Summary of evidence and guidelines for adjuvant therapy",
Recommendations,Strength rating
"Offer adjuvant cisplatin-based combination chemotherapy to patients with pT3/4 and/or 
pN+ disease if no neoadjuvant chemotherapy has been given.",Strong
"Offer adjuvant nivolumab to selected patients with pT3/4 and/or pN+ disease not eligible 
for, or who declined, adjuvant cisplatin-based chemotherapy.",Weak
